Cargando…

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis

BACKGROUND: Wiskott-Aldrich syndrome protein family member 2 (WASF2) has been shown to play an important role in many types of cancer. Therefore, it is worthwhile to further study expression profile of WASF2 in human cancer, which provides new molecular clues about the pathogenesis of ovarian cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaofeng, Ding, Yuzhen, Sun, Lu, Shi, Meiting, Zhang, Ping, He, Andong, Zhang, Xiaotan, Huang, Zhengrui, Li, Ruiman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964075/ https://www.ncbi.nlm.nih.gov/pubmed/35359421 http://dx.doi.org/10.3389/fonc.2022.840038

Ejemplares similares

Ferroptosis-Related Proteins Are Potential Diagnostic Molecular Markers for Patients with Preeclampsia
por: Shi, Meiting, et al.
Publicado: (2022)

Ferroptosis-related gene expression in the pathogenesis of preeclampsia
por: Ding, Yuzhen, et al.
Publicado: (2022)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Ferritin light chain deficiency-induced ferroptosis is involved in preeclampsia pathophysiology by disturbing uterine spiral artery remodelling
por: Yang, Xiaofeng, et al.
Publicado: (2022)

Targeting WASF3 Signaling in Metastatic Cancer
por: Loveless, Reid, et al.
Publicado: (2021)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

Development of a prediction model on preeclampsia using machine learning-based method: a retrospective cohort study in China
por: Liu, Mengyuan, et al.
Publicado: (2022)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
por: Zhang, Fang, et al.
Publicado: (2023)

Purified Vitexin Compound 1 Serves as a Promising Antineoplastic Agent in Ovarian Cancer
por: Ma, Kewen, et al.
Publicado: (2021)

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
por: Zeng, Tao, et al.
Publicado: (2023)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

Ancient genes can be served as pan‐cancer diagnostic and prognostic biomarkers
por: Ji, Xiangwen, et al.
Publicado: (2020)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Hypermethylated WASF2: tumor suppressive role in head and neck squamous cell carcinoma
por: Zhang, Jianyun, et al.
Publicado: (2022)

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
por: Kumar, Juhi, et al.
Publicado: (2019)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer
por: Li, Yue, et al.
Publicado: (2021)

Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases
por: Teng, Y, et al.
Publicado: (2010)

Suppression of Breast Cancer Metastasis Using Stapled Peptides Targeting the WASF Regulatory Complex
por: Cowell, John K, et al.
Publicado: (2017)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

Plasma-Derived Extracellular Vesicles Circular RNAs Serve as Biomarkers for Breast Cancer Diagnosis
por: Lin, Li, et al.
Publicado: (2021)

Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
por: Howard, David, et al.
Publicado: (2022)

Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
por: Clark, James, et al.
Publicado: (2022)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Potential Protein Biomarkers for Preeclampsia
por: He, Andong, et al.
Publicado: (2020)

miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3
por: Wang, Guojun, et al.
Publicado: (2017)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights
por: Zhang, Danfeng, et al.
Publicado: (2023)

Aggresome–Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma
por: Zhang, Zhiyong, et al.
Publicado: (2021)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer
por: Zheng, Jianfeng, et al.
Publicado: (2021)

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker
por: Zhang, Jingwen, et al.
Publicado: (2021)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

LAMP2 as a Biomarker Related to Prognosis and Immune Infiltration in Esophageal Cancer and Other Cancers: A Comprehensive Pan-Cancer Analysis
por: Liu, Shan-peng, et al.
Publicado: (2022)

MicroRNA‐93 targets WASF3 and functions as a metastasis suppressor in breast cancer
por: Shibuya, Naoki, et al.
Publicado: (2020)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i07umj4743dfil9u21lkoo81a9